Updated drug information handout outdoes FDA’s version
A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an updated version developed by researchers at the University of Pittsburgh that quantifies a drug’s risk and benefits showed that the latter was more informative and helped patients feel better equipped to make decisions.
Published today in JAMA Network Open, the study, which used the drug mifepristone as an example, highlights the importance of communicating risks and benefits of prescription medications – ...














